121 related articles for article (PubMed ID: 22390981)
1. Fungicidal amounts of antifungals are released from impregnated denture lining material for up to 28 days.
Salim N; Moore C; Silikas N; Satterthwaite JD; Rautemaa R
J Dent; 2012 Jun; 40(6):506-12. PubMed ID: 22390981
[TBL] [Abstract][Full Text] [Related]
2. Impregnation with antimicrobials challenge bonding properties and water sorption behaviour of an acrylic liner.
Salim N; Satterthwaite JD; Rautemaa R; Silikas N
J Dent; 2012 Aug; 40(8):693-9. PubMed ID: 22580350
[TBL] [Abstract][Full Text] [Related]
3. Candidacidal effect of fluconazole and chlorhexidine released from acrylic polymer.
Salim N; Moore C; Silikas N; Satterthwaite J; Rautemaa R
J Antimicrob Chemother; 2013 Mar; 68(3):587-92. PubMed ID: 23171950
[TBL] [Abstract][Full Text] [Related]
4. Chlorhexidine-impregnated PEM/THFM polymer exhibits superior activity to fluconazole-impregnated polymer against Candida albicans biofilm formation.
Salim N; Silikas N; Satterthwaite JD; Moore C; Ramage G; Rautemaa R
Int J Antimicrob Agents; 2013 Feb; 41(2):193-6. PubMed ID: 23127479
[TBL] [Abstract][Full Text] [Related]
5. Impregnation with antimicrobials has an impact on degree of conversion and colour stability of acrylic liner.
Salim N; Satterthwaite J; Rautemaa R; Silikas N
Dent Mater J; 2012; 31(6):1008-13. PubMed ID: 23207208
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
7. Resins-based denture soft lining materials modified by chlorhexidine salt incorporation: an in vitro analysis of antifungal activity, drug release and hardness.
Bertolini MM; Portela MB; Curvelo JA; Soares RM; Lourenço EJ; Telles DM
Dent Mater; 2014 Aug; 30(8):793-8. PubMed ID: 24933229
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
9. An in vitro analysis of a sustained release system for the treatment of denture stomatitis.
Schneid TR
Spec Care Dentist; 1992; 12(6):245-50. PubMed ID: 1308323
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
Lamfon H; Porter SR; McCullough M; Pratten J
J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
[TBL] [Abstract][Full Text] [Related]
11. An antifungal coating for dental silicones composed of chlorhexidine nanoparticles.
Garner SJ; Nobbs AH; McNally LM; Barbour ME
J Dent; 2015 Mar; 43(3):362-72. PubMed ID: 25511302
[TBL] [Abstract][Full Text] [Related]
12. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
[TBL] [Abstract][Full Text] [Related]
13. Effect of antifungal gels incorporated into a tissue conditioning material on the growth of Candida albicans.
Radnai M; Whiley R; Friel T; Wright PS
Gerodontology; 2010 Dec; 27(4):292-6. PubMed ID: 19732159
[TBL] [Abstract][Full Text] [Related]
14. Chlorhexidine is a highly effective topical broad-spectrum agent against Candida spp.
Salim N; Moore C; Silikas N; Satterthwaite J; Rautemaa R
Int J Antimicrob Agents; 2013 Jan; 41(1):65-9. PubMed ID: 23084595
[TBL] [Abstract][Full Text] [Related]
15. Rechargeable anticandidal denture material with sustained release in saliva.
Malakhov A; Wen J; Zhang BX; Wang H; Geng H; Chen XD; Sun Y; Yeh CK
Oral Dis; 2016 Jul; 22(5):391-8. PubMed ID: 26855200
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
17. In vitro antifungal activity of two tissue conditioners combined with nystatin, miconazole and fluconazole against Candida albicans.
Chopde N; Pharande A; Khade MN; Khadtare YR; Shah SS; Apratim A
J Contemp Dent Pract; 2012 Sep; 13(5):695-8. PubMed ID: 23250177
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients.
Traboulsi RS; Mukherjee PK; Ghannoum MA
Int J Antimicrob Agents; 2008 Mar; 31(3):272-6. PubMed ID: 18242063
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of antifungal activity of melaleuca oil and fluconazole when incorporated in tissue conditioner: an in vitro study.
Sharma S; Hegde V
J Prosthodont; 2014 Jul; 23(5):367-73. PubMed ID: 24393097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
